4.70% -0.0118

アフターアワーズ： .24 0.001 +0.42%

Azitra Inc (AZTR)

概要ニュース株価時系列ディスカッション予測

Azitra Inc (AZTR) 最新ニュース

Azitra Inc (AZTR)

Azitra Inc (AZTR) 最新ニュース

Azitra Inc Plans Stock Increase at Annual Meeting - TipRanks

Azitra reports safety data from Netherton syndrome treatment trial - Investing.com

Azitra reports safety data from Netherton syndrome treatment trial By Investing.com - Investing.com South Africa

AZTR’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com

Azitra Inc Announces Positive Phase 1b Trial Results - TipRanks

Azitra Reports Promising Safety Data from Phase 1b Trial in Netherton Syndrome - PR Newswire

Azitra (NYSEAMERICAN:AZTR) Stock Price Up 2% – Still a Buy? - Defense World

Azitra Inc (AZTR) Stock: A Year of Market Fluctuations - investchronicle.com

Azitra Reveals Latest Clinical Progress: Two Novel Dermatology Treatments Take Center Stage at BIO 2025 - Stock Titan

Revolutionary Skin Microbiome Treatment Could Help Cancer Patients Stay on Life-Saving Therapy - Stock Titan

FY2025 EPS Estimates for Azitra Lifted by Zacks Small Cap - Defense World

What is Zacks Small Cap’s Forecast for Azitra Q2 Earnings? - Defense World

AZTR: ATR-04 Trial to Dose 1st Patient Mid-2025 - MSN

Azitra (NYSEAMERICAN:AZTR) Trading Up 0.9% – Time to Buy? - Defense World

Azitra, Inc. to Present Abstract at American Society of Gene and Cell Therapy Highlighting Phase 1/2 Study Targeting Cancer Therapy-Associated Rash - Seeking Alpha

Azitra, Inc. Announces Q1 2025 Results and Provides Business Updates - Nasdaq

Azitra Advances Novel Skin Disease Treatments: Key Trial Results Expected in 2025 - Stock Titan

AZTRAzitra Inc Latest Stock News & Market Updates - Stock Titan

Stock Of Azitra Inc (AMEX: AZTR) Jumped By 6.67 Percent Over The Past Month, Is There Room For Upside? - Marketing Sentinel

Azitra Inc (AZTR)’s Day in Review: Closing at 0.30, Down by -6.51 - DWinneX

Azitra Inc (AZTR) Stock: Navigating Drops and Gains - investchronicle.com

Azitra Inc [AZTR] Investment Appeal on the Rise - knoxdaily.com

Azitra Inc (AMEX:AZTR) stock: You might be surprised - uspostnews.com

Stocks of Azitra Inc (AZTR) are poised to climb above their peers - Sete News

Azitra (AZTR) Secures Funding Through $20 Million Share Purchase Agreement - GuruFocus

What to expect from Azitra Inc’s (AZTR) current quarter earnings? - uspostnews.com

AZTR’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com

Branford-based biopharma Azitra Inc. gains $20M in partnership deal with Alumni Capital - Hartford Business Journal

Azitra (AZTR) to Highlight Precision Dermatology Advances at Bru - GuruFocus

Market Momentum: Azitra Inc (AZTR) Registers a 3.73 Increase, Closing at 0.31 - DWinneX

Azitra, Inc. to Present ATR-04 Program Update at ASCO 2025 - The Victoria Advocate

Why Coursera Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket - Benzinga

Azitra enters share purchase agreement with Alumni Capital for up to $20M - MSN

Azitra secures funding deal for dermatology treatments By Investing.com - Investing.com India

Azitra secures funding deal for dermatology treatments - Investing.com

$20M Strategic Investment Accelerates Azitra's Breakthrough Treatments for 150,000 Rare Disease Patients - Stock Titan

Azitra (NYSEAMERICAN:AZTR) Trading Up 3.9% – Here’s Why - Defense World

Azitra Announces Proposed Public Offering of Common Stock (PR Newswire) - Aktiellt

Azitra, Inc. (NYSEAMERICAN:AZTR) Shares Acquired by Virtu Financial LLC - Defense World

Teacher Retirement System of Texas Makes New $236,000 Investment in Grail, Inc. (NASDAQ:GRAL) - Defense World

Azitra (AZTR) Expected to Announce Quarterly Earnings on Friday - Defense World

Azitra to Present at Microbiome Times Partnering Forum – Company Announcement - Financial Times

Azitra to Present at Microbiome Times Partnering Forum - PR Newswire

Microbiome Disease Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 140+ Companies and 180+ Therapies | DelveInsight - GlobeNewswire

AZTR: Netherton Topline Expected by Year-End - MSN

Azitra, Inc. (NYSEAMERICAN:AZTR) Short Interest Up 144.1% in February - Defense World

Azitra, Inc. Announces Full Year 2024 Financial Results and Provides Business Updates - Citizentribune

Azitra, Inc. Announces FY 2024 Financial Results and Business Updates - Defense World

Maxim Group cuts Azitra stock price target to $2 from $3, retains Buy rating - Investing.com

Maxim Group cuts Azitra stock price target to $2 from $3, retains Buy rating By Investing.com - Investing.com South Africa

AZTRに似た銘柄